RGNX
REGENXBIO Inc.
NASDAQHealthcareBiotechnologyUS
Rating:D+
Company Profile
CEO
Curran Simpson
IPO Date
2015-09-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
REGENXBIO Inc.
CEO
Curran Simpson
IPO Date
2015-09-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 1,453 |
| $10.18 |
| 6 Jul 2026 | Simpson Curran | director, officer: Chief Executive Officer | F-InKind | Disposed | 6,818 | $13.09 |
| 6 Jul 2026 | PAKOLA STEVE | Chief Medical Officer | M-Exempt | Acquired | 2,161 | $7.86 |
| 6 Jul 2026 | PAKOLA STEVE | Chief Medical Officer | S-Sale | Disposed | 2,161 | $13.64 |
| 6 Jul 2026 | PAKOLA STEVE | Chief Medical Officer | M-Exempt | Disposed | 2,161 | $7.86 |
| 1 Jul 2026 | PAKOLA STEVE | Chief Medical Officer | S-Sale | Disposed | 19,608 | $11.04 |
| 1 Jul 2026 | PAKOLA STEVE | Chief Medical Officer | M-Exempt | Acquired | 36,725 | $7.86 |
| 1 Jul 2026 | PAKOLA STEVE | Chief Medical Officer | S-Sale | Disposed | 36,725 | $12.86 |
| 1 Jul 2026 | PAKOLA STEVE | Chief Medical Officer | M-Exempt | Disposed | 36,725 | $7.86 |